<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med. Technol.</journal-id><journal-title-group>
<journal-title>Frontiers in Medical Technology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med. Technol.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2673-3129</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmedt.2026.1759039</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and kinetic evaluation of vitamin C-loaded contact lenses prepared by a simple soaking technique</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Lutfhyansyah</surname><given-names>Novan Rifky</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3301889/overview" />
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Butt</surname><given-names>Haider</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1571337/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Mechanical &#x0026; Nuclear Engineering, Khalifa University of Science and Technology</institution>, <city>Abu Dhabi</city>, <country country="ae">United Arab Emirates</country></aff>
<aff id="aff2"><label>2</label><institution>Advanced Digital &#x0026; Additive Manufacturing (ADAM) Center, Khalifa University of Science and Technology</institution>, <city>Abu Dhabi</city>, <country country="ae">United Arab Emirates</country></aff>
<aff id="aff3"><label>3</label><institution>Food Security and Technology Center (FSTC), Khalifa University of Science and Technology</institution>, <city>Abu Dhabi</city>, <country>United Arab Emirates</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Novan Rifky Lutfhyansyah <email xlink:href="mailto:100065187@ku.ac.ae">100065187@ku.ac.ae</email> Haider Butt <email xlink:href="mailto:haider.butt@ku.ac.ae">haider.butt@ku.ac.ae</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-26"><day>26</day><month>02</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2026</year></pub-date>
<volume>8</volume><elocation-id>1759039</elocation-id>
<history>
<date date-type="received"><day>02</day><month>12</month><year>2025</year></date>
<date date-type="rev-recd"><day>18</day><month>01</month><year>2026</year></date>
<date date-type="accepted"><day>02</day><month>02</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Lutfhyansyah and Butt.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Lutfhyansyah and Butt</copyright-holder><license><ali:license_ref start_date="2026-02-26">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract>
<p>Conventional ocular drug delivery systems are often limited by low bioavailability and short residence times at the ocular surface, motivating the development of alternative delivery platforms. In this study, vitamin C-loaded contact lenses were prepared using a simple soaking technique and systematically evaluated. Two commercial lenses, Senofilcon A and Hilafilcon B, were immersed in vitamin C solutions, and their loading efficiency, release kinetics, stability, water content, and oxygen permeability were investigated. Vitamin C release was quantified using UV-Vis spectrometry and analyzed using zero-order, first-order, Higuchi, and Korsmeyer&#x2013;Peppas models. Hilafilcon B exhibited higher vitamin C loading and cumulative release (&#x223C;14&#x2005;&#x00B5;g/mL) than Senofilcon A (&#x223C;10&#x2005;&#x00B5;g/mL), consistent with its higher hydrophilicity and equilibrium water content (&#x223C;56&#x0025; compared to &#x223C;29&#x0025;). Kinetic analysis indicated that the vitamin C release from both lenses was best described by the Korsmeyer&#x2013;Peppas model (Hilafilcon B, <italic>n</italic>&#x2009;&#x003D;&#x2009;0.610; Senofilcon A, <italic>n</italic>&#x2009;&#x003D;&#x2009;0.783), suggesting anomalous transport behavior. Vitamin C stability was strongly influenced by storage conditions, with refrigerated storage improving stability, while UV exposure accelerated degradation. Overall, these findings demonstrate that vitamin C incorporation via soaking provides a straightforward approach for developing antioxidant-loaded contact lenses with potential relevance for ocular drug delivery.</p>
</abstract>
<kwd-group>
<kwd>contact lenses</kwd>
<kwd>drug delivery</kwd>
<kwd>mathematical models</kwd>
<kwd>release kinetics</kwd>
<kwd>vitamin C</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This research was funded by Khalifa University of Science and Technology through the Research Innovation Grant (RIG) under Project ID: KU-INT-RIG-2024-8474000736.</funding-statement></funding-group><counts>
<fig-count count="9"/>
<table-count count="6"/><equation-count count="6"/><ref-count count="42"/><page-count count="12"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Diagnostic and Therapeutic Devices</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Conventional topical drug delivery methods for ophthalmic applications, such as eye drops, face significant challenges due to low bioavailability and poor ocular drug penetration. These limitations are largely due to the eye&#x0027;s natural defense mechanisms, including tear turnover, blinking, and various anatomical barriers that restrict drug absorption (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). As a result, only a small fraction, typically between 1&#x0025;&#x2013;5&#x0025;, of the administered dose actually reaches intraocular tissues.</p>
<p>To compensate for these limitations, higher drug concentrations and frequent administration are often required. This not only increases the risk of local and systemic side effects but also negatively affects patient compliance, especially in chronic conditions like glaucoma or dry eye syndrome (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). The inefficiency of traditional eye drop formulations has prompted the development of alternative drug delivery systems aimed at enhancing therapeutic efficacy and patient convenience.</p>
<p>One promising alternative is the use of drug-eluting contact lenses. These devices can deliver drugs directly and continuously to the ocular surface, significantly enhancing bioavailability while minimizing systemic exposure (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Furthermore, drug-eluting contact lenses offer considerable design flexibility, allowing customization of lens materials, drug type, and loading strategies to address specific ocular conditions and patient-specific therapeutic requirements, similar to other polymer-based drug delivery systems (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Overall, compared to eye drops, contact lenses provide a larger surface area for drug absorption and can extend drug residence time, potentially reducing the frequency of administration and thereby improving therapeutic efficacy.</p>
<p>Vitamin C (ascorbic acid) is a vital compound for maintaining ocular health due to its potent antioxidant properties and exceptionally high concentration in the eye. The vitamin C level in the aqueous humor ranges between 1 and 2&#x2005;mM, approximately 40 times higher than in the blood, accounting for about 75&#x0025; of the total antioxidant potential in this region (<xref ref-type="bibr" rid="B10">10</xref>). This elevated concentration highlights its crucial role in neutralizing reactive oxygen species (ROS) and safeguarding ocular structures, including the cornea, lens, and retina, from oxidative damage. Reduced levels of vitamin C have been detected in individuals suffering from ocular disorders such as cataracts, Lowe&#x0027;s syndrome, exfoliation syndrome, and glaucoma (<xref ref-type="bibr" rid="B11">11</xref>). Studies have shown that vitamin C helps prevent oxidative stress-related ocular diseases, including cataracts, glaucoma, and age-related macular degeneration (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). For example, vitamin C has been reported to protect the lens and trabecular meshwork by consuming oxygen in the vitreous, thereby reducing oxidative degradation (<xref ref-type="bibr" rid="B10">10</xref>). Clinically, its therapeutic potential has been observed in animal corneal health, where topical vitamin C promoted wound healing and prevented endothelial cell loss after cataract surgery (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Moreover, its biological role extends to stimulating collagen type I synthesis, supporting epithelial regeneration, and enhancing tissue repair capacity (<xref ref-type="bibr" rid="B17">17</xref>). Altogether, these findings emphasize that vitamin C is not merely an antioxidant but a multifunctional molecule indispensable for preserving ocular integrity, preventing oxidative injury, and maintaining long-term visual health.</p>
<p>Despite its therapeutic importance, effective ocular delivery of vitamin C remains challenging due to limitations of both systemic and topical administration. Systemic delivery must overcome numerous static and dynamic ocular barriers, including the blood-aqueous and blood-retinal barriers, which restrict the passage of circulating compounds into ocular tissues (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Conventional eye drops also demonstrate low bioavailability, which can limit therapeutic effectiveness. Additionally, vitamin C solutions are susceptible to oxidative degradation, which further reduces the concentration of active vitamin C (<xref ref-type="bibr" rid="B20">20</xref>). Accordingly, drug-eluting contact lenses offer a potential strategy to enhance local delivery by extending residence time on the ocular surface and minimizing early oxidation of vitamin C.</p>
<p>The drug release behavior from polymeric systems is typically analyzed using mathematical models, such as zero-order, first-order, Higuchi, and Korsmeyer-Peppas models, to determine the underlying release mechanisms. Zero-order kinetics describe a constant drug release rate that is independent of drug concentration, which is ideal for maintaining stable therapeutic levels (<xref ref-type="bibr" rid="B21">21</xref>). First-order kinetics indicate that the release rate is proportional to the remaining drug content within the system (<xref ref-type="bibr" rid="B21">21</xref>). The Higuchi model explains drug release as a diffusion-controlled process based on Fick&#x0027;s law, commonly applicable to systems where the drug diffuses through a porous or swollen matrix (<xref ref-type="bibr" rid="B21">21</xref>). The Korsmeyer-Peppas model provides further mechanistic insight by distinguishing between Fickian diffusion, anomalous transport (a combination of diffusion and polymer relaxation), and case II transport (polymer relaxation or swelling-controlled release) through the release exponent (<xref ref-type="bibr" rid="B21">21</xref>). Collectively, these models help elucidate how the properties of the polymer matrix and lens material influence drug release profiles, which is critical for the rational design and optimization of drug-eluting contact lenses (<xref ref-type="bibr" rid="B22">22</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>). Applying these models enables a deeper understanding of vitamin C release performance and supports the development of improved formulations in future studies.</p>
<p>Although research on drug-eluting contact lenses has advanced considerably in recent years, to the best of our knowledge, no studies have reported the incorporation of vitamin C into contact lenses for sustained ocular delivery. Given vitamin C&#x0027;s established role in ocular protection and tissue repair, this represents an unexplored yet promising direction within the broader field of therapeutic contact lenses. Therefore, this study aims to develop vitamin C-loaded contact lenses utilizing a straightforward soaking technique. We examine the incorporation efficiency and drug release kinetic profile of vitamin C from the commercial lenses. Additionally, we assess the stability of vitamin C under various conditions to optimize the loading method into contact lenses. Furthermore, we measure the water content to evaluate the impact of vitamin C addition on the lenses&#x0027; water retention capacity and oxygen permeability. The present study aims to establish a foundational approach for the utilization of vitamin C in future therapeutic applications in ophthalmology.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Materials and methods</title>
<p><xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref> presents an overview of the experimental workflow conducted in this study, including the preparation of the drug solution, the incorporation of the drug into commercial contact lenses, the drug release study, and supporting analyses for stability, water content, and oxygen permeability. The details of each component are provided in the following sections.</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Overview of the experimental workflow, including vitamin C solution preparation, incorporation into commercial contact lenses, release study, and supporting analyses for stability, water content, and oxygen permeability.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g001.tif"><alt-text content-type="machine-generated">Flowchart illustrating an experimental process with commercial contact lenses (Senofilcon A, Hilafilcon B), vitamin C solution preparation, incorporation by soaking, release study, and kinetic modeling, alongside supporting vitamin C stability and permeability measurements.</alt-text>
</graphic>
</fig>
<sec id="s2a"><label>2.1</label><title>Materials</title>
<p>In this study, two types of contact lenses were utilized. There are Senofilcon A from Acuvue Oasys with Hydraluxe (Dia 14.3&#x2005;mm, BC 8.5&#x2005;mm, <italic>P</italic> &#x2212;0.75) and Hilafilcon B from Bausch &#x0026; Lomb Soflens (Dia 14.2&#x2005;mm, BC 8.6&#x2005;mm, <italic>P</italic> &#x2212;1.00). L-Ascorbic Acid or vitamin C was obtained from Sigma-Aldrich. Moreover, phosphate-buffered saline (PBS) in the form of tablets (pH 7.3&#x2009;&#x00B1;&#x2009;0.2 at 25&#x00B0;C) was obtained from Oxoid. All chemicals were used as received without any further treatment.</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Vitamin C loading into contact lenses</title>
<p>To make the vitamin C solution, the PBS solution was prepared as the solvent. A single PBS tablet was dissolved in 100&#x2005;mL of deionized water, followed by heating at 115&#x00B0;C for 10&#x2005;min. The vitamin C solution was formulated by dissolving vitamin C powder in the PBS solution. To prepare the vitamin C-loaded contact lenses, the lenses were immersed in a 1,000&#x2005;&#x00B5;g/mL (1&#x2005;mg/mL) vitamin C solution for 6&#x2005;h and subsequently stored in a refrigerator (&#x223C;4&#x00B0;C). The soaking duration and temperature were selected to allow the lenses to reach equilibrium with the vitamin C solution while minimizing premature oxidation. <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref> shows the lenses before and after the incorporation of vitamin C.</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Contact lenses before and after vitamin C loading.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g002.tif"><alt-text content-type="machine-generated">Diagram showing two contact lenses, Senofilcon A and Hilafilcon B, on the left before soaking, and applied on artificial eyes on the right after soaking in 5 milliliters of vitamin C solution for six hours.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2c"><label>2.3</label><title>Vitamin C release study</title>
<p>The vitamin C-loaded contact lenses were immersed in a small jar containing 5&#x2005;mL of PBS solution. To simulate tear fluid drainage and renewal, a portion of the PBS was periodically withdrawn and replaced with fresh PBS every 30&#x2005;min. Specifically, 3&#x2005;mL of the solution was removed and replenished with an equal volume of fresh PBS at each interval. The collected aliquots were analyzed using a UV-Vis spectrometer (Ocean Insight Miniature Spectrometer) to monitor the release of vitamin C from the contact lenses. The release study was performed at 30&#x2005;min intervals for a total duration of 3&#x2005;h. The concentration of vitamin C in each aliquot was determined based on a predetermined calibration curve of vitamin C solutions. All release experiments were performed in triplicate (<italic>n</italic>&#x2009;&#x003D;&#x2009;3 for each commercial lens type).</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Kinetic release model of vitamin C release</title>
<p>Different mathematical models were applied to evaluate the kinetic release profiles of the samples over the studied time duration. These included zero-order and first-order release models, the Higuchi release model, and the Korsmeyer-Peppas model. The graphs are plotted, and the coefficient of determination (R<sup>2</sup>) of each model is determined according to the equation of each release model, as shown in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref> (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>). Additionally, the residual sum of squares (RSS), Akaike information criterion (AIC), and model selection criterion (MSC) are calculated to evaluate the validity of each model fitting.</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Various drug release kinetic model equations.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Parameter</th>
<th valign="top" align="center">Zero order</th>
<th valign="top" align="center">First order</th>
<th valign="top" align="center">Higuchi model</th>
<th valign="top" align="center">Korsmeyer-Peppas model</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Equation</td>
<td valign="top" align="left"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM1"><mml:msub><mml:mi>C</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>C</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>K</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:math></inline-formula></td>
<td valign="top" align="left"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM2"><mml:mi>log</mml:mi><mml:mspace width="0.2em"/><mml:msub><mml:mi>C</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>log</mml:mi><mml:mspace width="0.2em"/><mml:msub><mml:mi>C</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mn>2.303</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>t</mml:mi></mml:math></inline-formula></td>
<td valign="top" align="left"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM3"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi mathvariant="normal">&#x221E;</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>K</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula></td>
<td valign="top" align="left"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM4"><mml:mi>log</mml:mi><mml:mspace width="0.2em"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi mathvariant="normal">&#x221E;</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>log</mml:mi><mml:mspace width="0.2em"/><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mi>n</mml:mi><mml:mi>log</mml:mi><mml:mspace width="0.2em"/><mml:mi>t</mml:mi></mml:math></inline-formula></td>
</tr>
<tr>
<td valign="top" align="left">Graph</td>
<td valign="top" align="left">Cumulative drug release vs. time</td>
<td valign="top" align="left">log cumulative &#x0025; drug remaining vs. time</td>
<td valign="top" align="left">Cumulative &#x0025; drug release vs. <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM5"><mml:msqrt><mml:mi>t</mml:mi></mml:msqrt></mml:math></inline-formula></td>
<td valign="top" align="left">log cumulative &#x0025; drug release vs. log t</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2e"><label>2.5</label><title>Vitamin C stability study</title>
<p>To investigate the stability of vitamin C under different storage conditions, two solutions of 10&#x2005;&#x00B5;g/mL vitamin C were prepared and stored either in a closed drawer at room temperature (&#x223C;22&#x2005;&#x00B0;C) and inside a refrigerator (&#x223C;4&#x00B0;C). The UV spectra were recorded before and after a 24&#x2005;h storage period. Additionally, the photostability of vitamin C was examined by exposing a 10&#x2005;&#x00B5;g/mL solution to UV light (<italic>&#x03BB;</italic>&#x2009;&#x003D;&#x2009;365&#x2005;nm) using a UV chamber (Analytik Jena, Germany). The spectra were collected at 60&#x2005;min intervals over the exposure period. All UV stability tests were performed at room temperature.</p>
</sec>
<sec id="s2f"><label>2.6</label><title>Water content measurement</title>
<p>The water content study is conducted to see the effect of vitamin C on the water uptake capacity of the contact lenses. The lenses were dried using an oven at 60&#x00B0;C for 60&#x2005;min, and then the dry weight was measured. Then, the lenses are soaked in DI water, PBS solution, and vitamin C solution for a particular time, and the weight is measured as the wet weight. Each measurement was performed in triplicate for both lens types (<italic>n</italic>&#x2009;&#x003D;&#x2009;3). The water content of the contact lenses can be calculated by the following equation:<disp-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="UDM1"><mml:mrow><mml:mi mathvariant="normal">Water</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">content</mml:mi><mml:mspace width="0.25em"/></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>&#x0025;</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Wet</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">weight</mml:mi></mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mrow><mml:mi mathvariant="normal">Dry</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">weight</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Wet</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">weight</mml:mi></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:mspace width="0.25em"/><mml:mo>&#x00D7;</mml:mo><mml:mn>100</mml:mn><mml:mtext>&#x0025;</mml:mtext></mml:mrow></mml:mstyle></mml:math></disp-formula>Additionally, the oxygen permeability (Dk) of each lens was estimated using the Morgan and Efron empirical relationship, expressed as Dk&#x2009;&#x003D;&#x2009;1.67e<sup>0.00397EWC</sup>, where EWC is the equilibrium water content of the material (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B29">29</xref>).</p>
</sec>
<sec id="s2g"><label>2.7</label><title>Statistical evaluation</title>
<p>All quantitative measurements were performed in triplicate (<italic>n</italic>&#x2009;&#x003D;&#x2009;3). Statistical comparisons between Senofilcon A and Hilafilcon B were conducted using unpaired two-sample t-tests, with <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 considered statistically significant. Statistical analyses were performed using Microsoft Excel.</p>
</sec>
</sec>
<sec id="s3"><label>3</label><title>Results and discussion</title>
<p>The detection of the vitamin C molecule can be accomplished using a UV spectrometer, which reveals a characteristic peak at around 265&#x2005;nm. <xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref> displays the transmittance and absorbance of various concentrations of vitamin C solution. Additionally, a standard curve was constructed from the absorption data, allowing for the determination of unknown vitamin C concentrations. The figure clearly shows that the peaks indicating vitamin C fall within the range of 265.196&#x2005;nm to 267.049&#x2005;nm, similar to previously reported values in the literature (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>). As the concentration increases, the peak wavelength also rises. While variations in peak wavelength are common, this observation might imply that a higher concentration of vitamin C requires slightly less energy to induce molecular vibrations.</p>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>The <bold>(a)</bold> transmittance and <bold>(b)</bold> absorbance of vitamin C solution with various concentrations to construct the <bold>(c)</bold> standard curve of vitamin C solution.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g003.tif"><alt-text content-type="machine-generated">Panel a shows a line graph of transmittance versus wavelength for four concentrations, with a minimum near 267 nanometers. Panel b presents absorbance versus wavelength for the same concentrations, also peaking near 267 nanometers. Panel c displays a scatter plot with a fitted linear regression line of absorbance versus concentration, with R squared value 0.98678.</alt-text>
</graphic>
</fig>
<p>Vitamin C is prone to degradation, especially when exposed to light and oxygen. Research has demonstrated that storage conditions greatly influence the stability of vitamin C (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Consequently, we examined how different storage conditions affect the stability of vitamin C solutions, as illustrated in <xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>. Furthermore, we also explored the stability of vitamin C when exposed to UV light, as depicted in <xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref> and <xref ref-type="table" rid="T2">Table&#x00A0;2</xref>.</p>
<fig id="F4" position="float"><label>Figure&#x00A0;4</label>
<caption><p>The absorbance of the vitamin C solution with <bold>(a)</bold> 5&#x2005;&#x00B5;g/mL stored in a fridge and <bold>(b)</bold> 10&#x2005;&#x00B5;g/mL stored at room temperature.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g004.tif"><alt-text content-type="machine-generated">Panel a shows a line graph of absorbance versus wavelength for fresh and three-hour-old samples with similar peaks around 270 nanometers. Panel b shows three lines for fresh, three-hour, and twenty-four-hour samples. The twenty-four-hour sample, shown in blue, has significantly lower absorbance. Both panels compare sample stability over time by UV-Vis spectroscopy.</alt-text>
</graphic>
</fig>
<fig id="F5" position="float"><label>Figure&#x00A0;5</label>
<caption><p>The <bold>(a)</bold> transmittance and <bold>(b)</bold> absorbance of vitamin C solution after UV exposure. The <bold>(c)</bold> concentration and degradation percentage of vitamin C solution during the stability test.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g005.tif"><alt-text content-type="machine-generated">Panel a shows a line graph of transmittance percentage versus wavelength for ascorbic acid over time, with lines for initial, one, two, three, four, and twenty-four hours. Panel b displays a similar line graph for absorbance versus wavelength, showing decreasing absorbance over the same time intervals. Panel c presents a dual-axis graph of ascorbic acid concentration and percentage degradation over time, depicting a drop in concentration and rise in degradation after UV exposure, with a chemical structure diagram of ascorbic and dehydroascorbic acid shown in the middle.</alt-text>
</graphic>
</fig>
<table-wrap id="T2" position="float"><label>Table&#x00A0;2</label>
<caption><p>The concentration of vitamin C after UV exposure.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Time</th>
<th valign="top" align="center">Concentration (&#x03BC;g/mL)</th>
<th valign="top" align="center">Degradation (&#x0025;)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Initial</td>
<td valign="top" align="center">9.434</td>
<td valign="top" align="center">0</td>
</tr>
<tr>
<td valign="top" align="left">1&#x2005;h</td>
<td valign="top" align="center">8.304</td>
<td valign="top" align="center">11.98</td>
</tr>
<tr>
<td valign="top" align="left">2&#x2005;h</td>
<td valign="top" align="center">7.874</td>
<td valign="top" align="center">16.54</td>
</tr>
<tr>
<td valign="top" align="left">3&#x2005;h</td>
<td valign="top" align="center">7.082</td>
<td valign="top" align="center">24.93</td>
</tr>
<tr>
<td valign="top" align="left">4&#x2005;h</td>
<td valign="top" align="center">6.391</td>
<td valign="top" align="center">32.26</td>
</tr>
<tr>
<td valign="top" align="left">24&#x2005;h&#x002A;</td>
<td valign="top" align="center">5.871</td>
<td valign="top" align="center">37.77</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF2a"><p>&#x002A;&#x2009;&#x003D;&#x2009;measured at 24 h after solution preparation; UV exposure was stopped after 4 h.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The effect of storage temperature on the degradation of vitamin C is illustrated in <xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>. <xref ref-type="fig" rid="F4">Figure&#x00A0;4a</xref> presents the absorbance of a 5&#x2005;&#x00B5;g/mL vitamin C solution stored in a refrigerator, while <xref ref-type="fig" rid="F4">Figure&#x00A0;4b</xref> displays the absorbance of a 10&#x2005;&#x00B5;g/mL vitamin C solution stored at ambient temperature. After a duration of 3&#x2005;h, the 5&#x2005;&#x00B5;g/mL vitamin C solution stored in the refrigerator exhibits a lesser degree of degradation, with the concentration decreasing by approximately 2.99&#x0025; from the initial concentration. In contrast, the 10&#x2005;&#x00B5;g/mL vitamin C solution stored at room temperature shows a reduction of up to 19.77&#x0025; from its initial concentration. Furthermore, after 24&#x2005;h, the 10&#x2005;&#x00B5;g/mL vitamin C solution degrades by up to 40.03&#x0025;. These findings suggest that the optimal condition for employing the soaking method to load vitamin C into lenses is best achieved when conducted in a refrigerated environment.</p>
<p><xref ref-type="fig" rid="F5">Figures&#x00A0;5a,b</xref> show the absorbance and transmittance spectra of the vitamin C solution before and after UV exposure, while <xref ref-type="fig" rid="F5">Figure&#x00A0;5c</xref> and <xref ref-type="table" rid="T2">Table&#x00A0;2</xref> summarize the corresponding changes in concentration and degradation percentage. The results clearly indicate that UV irradiation accelerated the degradation of vitamin C. After 4&#x2005;h of exposure to 365&#x2005;nm UV light, the vitamin C concentration decreased by 32.26&#x0025;, whereas during 20&#x2005;h of storage at room temperature, only about 5&#x0025; degradation occurred, leaving 37.77&#x0025; of the initial concentration. This demonstrates that UV radiation substantially enhanced the rate of vitamin C loss. The degradation mechanism is likely governed by indirect oxidative degradation, in which UV exposure generates reactive oxygen species (ROS) such as singlet oxygen and hydroxyl radicals from dissolved oxygen or residual impurities in the medium. These ROS subsequently oxidize ascorbic acid to dehydroascorbic acid and other breakdown products. Hence, the degradation is not primarily caused by direct photolysis, since ascorbic acid strongly absorbs at &#x223C;265&#x2005;nm, whereas the UV lamp used in this study emits at 365&#x2005;nm. Aguilar et al. (2019) similarly reported that UV-Vis irradiation did not significantly accelerate ascorbic acid degradation in aqueous solutions due to its low absorption within the lamp&#x0027;s emission range (<xref ref-type="bibr" rid="B35">35</xref>). Nevertheless, other studies have shown that UV exposure generally promotes ascorbic acid degradation through photo-oxidative mechanisms, aligning with the present findings (<xref ref-type="bibr" rid="B36">36</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>The transmittance and absorbance data for the vitamin C release study are presented in <xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>. The graphs clearly demonstrate that the peaks indicating vitamin C transmission in Hilafilcon B are lower than those in Senofilcon A. This suggests that Hilafilcon B has a higher capacity to absorb vitamin C compared to Senofilcon A. However, after 90&#x2005;min, no significant peaks are observed for either Senofilcon A or Hilafilcon B. Therefore, it implies that the vitamin C release rate of Hilafilcon B is greater than that of Senofilcon A.</p>
<fig id="F6" position="float"><label>Figure&#x00A0;6</label>
<caption><p>The <bold>(a)</bold> transmittance and <bold>(b)</bold> absorbance of PBS for the vitamin C release study for Senofilcon A; the <bold>(c)</bold> transmittance and <bold>(d)</bold> absorbance of PBS for the vitamin C release study for Hilafilcon B.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g006.tif"><alt-text content-type="machine-generated">Four-panel scientific figure comparing transmittance and absorbance of PBS over time as vitamin C is released from two contact lens materials. Panels a and c show percent transmittance versus wavelength for senofilcon A and hilafilcon B, respectively, with multiple lines representing different time points from thirty to one hundred eighty minutes. Panels b and d show corresponding absorbance (optical density) versus wavelength, also for both materials and time points, demonstrating increasing changes over time, most notably around two hundred sixty nanometers. Legends and axis labels are clearly included for all panels.</alt-text>
</graphic>
</fig>
<p>Based on the absorbance measurements at different time intervals, the concentration of vitamin C released from both Senofilcon A and Hilafilcon B lenses was determined, as shown in <xref ref-type="fig" rid="F7">Figure&#x00A0;7</xref> and summarized in <xref ref-type="table" rid="T3">Table&#x00A0;3</xref>. Both materials exhibited an initial burst release followed by a gradual decline in the release rate over time. However, statistical comparison using an unpaired t-test showed that Hilafilcon B released significantly more vitamin C than Senofilcon A at the early (30&#x2005;min), mid (120&#x2005;min), and final (180&#x2005;min) timepoints (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 for all comparisons). After 180&#x2005;min, Hilafilcon B reached a cumulative concentration of approximately 14&#x2005;&#x00B5;g/mL, whereas Senofilcon A reached about 10&#x2005;&#x00B5;g/mL. This indicates that Hilafilcon B released vitamin C more rapidly and in greater quantities in the initial steps than Senofilcon A, likely due to its higher water content and greater hydrophilicity, which facilitate faster molecular diffusion through the hydrogel matrix. After 90&#x2005;min, the release from both lenses began to plateau, suggesting that the diffusion process approached equilibrium as the concentration gradient diminished.</p>
<fig id="F7" position="float"><label>Figure&#x00A0;7</label>
<caption><p>Vitamin C release from Senofilcon A and Hilafilcon B lenses.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g007.tif"><alt-text content-type="machine-generated">Line graph comparing concentration over time for Senofilcon A and Hilafilcon B, with solid lines showing direct measurements and dashed lines showing cumulative values. Both cumulative values increase, with Hila-Cumulative reaching higher concentrations than Seno-Cumulative by 180 minutes. Direct concentrations for both materials decrease over time.</alt-text>
</graphic>
</fig>
<table-wrap id="T3" position="float"><label>Table&#x00A0;3</label>
<caption><p>Summary of vitamin C concentration released from Senofilcon A and Hilafilcon B.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Time (min)</th>
<th valign="top" align="center" colspan="2">Senofilcon A</th>
<th valign="top" align="center" colspan="2">Hilafilcon B</th>
</tr>
<tr>
<th valign="top" align="center">Concentration (&#x03BC;g/mL)</th>
<th valign="top" align="center">Cumulative concentration (&#x03BC;g/mL)</th>
<th valign="top" align="center">Concentration (&#x03BC;g/mL)</th>
<th valign="top" align="center">Cumulative concentration (&#x03BC;g/mL)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">30</td>
<td valign="top" align="center">2.270&#x2009;&#x00B1;&#x2009;0.012</td>
<td valign="top" align="center">2.270</td>
<td valign="top" align="center">3.960&#x2009;&#x00B1;&#x2009;0.082</td>
<td valign="top" align="center">3.960</td>
</tr>
<tr>
<td valign="top" align="left">60</td>
<td valign="top" align="center">1.703&#x2009;&#x00B1;&#x2009;0.126</td>
<td valign="top" align="center">3.973</td>
<td valign="top" align="center">2.336&#x2009;&#x00B1;&#x2009;0.046</td>
<td valign="top" align="center">6.296</td>
</tr>
<tr>
<td valign="top" align="left">90</td>
<td valign="top" align="center">1.446&#x2009;&#x00B1;&#x2009;0.096</td>
<td valign="top" align="center">5.419</td>
<td valign="top" align="center">1.693&#x2009;&#x00B1;&#x2009;0.032</td>
<td valign="top" align="center">7.989</td>
</tr>
<tr>
<td valign="top" align="left">120</td>
<td valign="top" align="center">1.282&#x2009;&#x00B1;&#x2009;0.032</td>
<td valign="top" align="center">6.701</td>
<td valign="top" align="center">1.362&#x2009;&#x00B1;&#x2009;0.039</td>
<td valign="top" align="center">9.351</td>
</tr>
<tr>
<td valign="top" align="left">150</td>
<td valign="top" align="center">1.322&#x2009;&#x00B1;&#x2009;0.043</td>
<td valign="top" align="center">8.022</td>
<td valign="top" align="center">1.320&#x2009;&#x00B1;&#x2009;0.044</td>
<td valign="top" align="center">10.671</td>
</tr>
<tr>
<td valign="top" align="left">180</td>
<td valign="top" align="center">1.283&#x2009;&#x00B1;&#x2009;0.021</td>
<td valign="top" align="center">9.305</td>
<td valign="top" align="center">1.288&#x2009;&#x00B1;&#x2009;0.047</td>
<td valign="top" align="center">11.959</td>
</tr>
</tbody>
</table>
</table-wrap>
<p><xref ref-type="fig" rid="F8">Figure&#x00A0;8</xref> illustrates the fitting of the experimental data to different kinetic models describing the release of vitamin C from Senofilcon A and Hilafilcon B lenses, with the corresponding statistical parameters summarized in <xref ref-type="table" rid="T4">Table&#x00A0;4</xref>. Both lenses demonstrated strong correlations (R&#x00B2;&#x2009;&#x2265;&#x2009;0.95) for all models except the first-order model, indicating that concentration-dependent kinetics do not adequately represent the release behavior of vitamin C in these systems. However, such high R&#x00B2; values should be interpreted with caution, as strong correlations can sometimes reflect model overfitting rather than true mechanistic accuracy. Moreover, the Higuchi and Korsmeyer-Peppas models exhibited the best agreement with the experimental data, suggesting that the release process is primarily governed by diffusion through the hydrogel matrix. According to the Korsmeyer-Peppas model, the release exponent (n) for both lenses lies within the range of 0.5&#x2009;&#x003C;&#x2009;<italic>n</italic>&#x2009;&#x003C;&#x2009;1, indicating that the mechanism follows anomalous transport, where both diffusion of vitamin C and polymer relaxation contribute to the overall release (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B40">40</xref>&#x2013;<xref ref-type="bibr" rid="B42">42</xref>). The lower <italic>n</italic> value for Hilafilcon B (<italic>n</italic>&#x2009;&#x003D;&#x2009;0.610) compared to Senofilcon A (<italic>n</italic>&#x2009;&#x003D;&#x2009;0.783) implies that the release from Hilafilcon B aligns more closely with Fickian diffusion, whereas Senofilcon A implies a more balanced contribution from diffusion and polymer matrix swelling or relaxation. Overall, based on the trends observed in the model fitting, these results suggest that the release of vitamin C from both materials is primarily diffusion-controlled, with the relative influence of relaxation or swelling effects varying between lens types.</p>
<fig id="F8" position="float"><label>Figure&#x00A0;8</label>
<caption><p>Kinetic model of <bold>(a)</bold> zero-order, <bold>(b)</bold> first-order, <bold>(c)</bold> Higuchi model, and <bold>(d)</bold> Korsmeyer-peppas model of vitamin C release from Senofilcon A and Hilafilcon B lenses.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g008.tif"><alt-text content-type="machine-generated">Four-panel figure showing release profile comparisons between Senofilcon A (red) and Hilafilcon B (blue). Panel a: cumulative concentration versus time, with Hilafilcon B higher. Panel b: log cumulative percent remaining versus time, both decrease, Hilafilcon B decays slower. Panel c: cumulative release percentage over square root of time, both linear but Hilafilcon B higher. Panel d: log cumulative percent release versus log time, both linear, Hilafilcon B above Senofilcon A. Legends and axes are clearly labeled.</alt-text>
</graphic>
</fig>
<table-wrap id="T4" position="float"><label>Table&#x00A0;4</label>
<caption><p>Summary of the release kinetic statistical evaluation of Senofilcon A and Hilafilcon B.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Sample</th>
<th valign="top" align="center">Parameter</th>
<th valign="top" align="center">Zero-order</th>
<th valign="top" align="center">First-order</th>
<th valign="top" align="center">Higuchi</th>
<th valign="top" align="center">Korsmeyer-Peppas</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="7">Senofilcon A</td>
<td valign="top" align="left">Linear regression equation</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;0.0463x&#x2009;&#x002B;&#x2009;1.0875</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;&#x2212;0.0052x&#x2009;&#x002B;&#x2009;2.1485</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;9.4827x&#x2009;&#x2212;&#x2009;30.7273</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;0.7826x&#x2009;&#x002B;&#x2009;0.2341</td>
</tr>
<tr>
<td valign="top" align="left">K</td>
<td valign="top" align="center">0.046</td>
<td valign="top" align="center">0.005</td>
<td valign="top" align="center">9.483</td>
<td valign="top" align="center">1.714</td>
</tr>
<tr>
<td valign="top" align="left">R<sup>2</sup></td>
<td valign="top" align="center">0.996</td>
<td valign="top" align="center">0.851</td>
<td valign="top" align="center">0.998</td>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">RSS</td>
<td valign="top" align="center">19.590</td>
<td valign="top" align="center">8.977</td>
<td valign="top" align="center">2,113.556</td>
<td valign="top" align="center">0.114</td>
</tr>
<tr>
<td valign="top" align="left">AIC</td>
<td valign="top" align="center">11.100</td>
<td valign="top" align="center">6.417</td>
<td valign="top" align="center">39.186</td>
<td valign="top" align="center">&#x2212;19.782</td>
</tr>
<tr>
<td valign="top" align="left">MSC</td>
<td valign="top" align="center">&#x2212;0.120</td>
<td valign="top" align="center">&#x2212;3.539</td>
<td valign="top" align="center">&#x2212;0.052</td>
<td valign="top" align="center">0.133</td>
</tr>
<tr>
<td valign="top" align="left"><italic>n</italic></td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">0.783</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="7">Hilafilcon B</td>
<td valign="top" align="left">Linear regression equation</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;0.0519x&#x2009;&#x002B;&#x2009;2.9228</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;&#x2212;0.003x&#x2009;&#x002B;&#x2009;2.0094</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;8.2376x&#x2009;&#x2212;&#x2009;11.6376</td>
<td valign="top" align="center">y&#x2009;&#x003D;&#x2009;0.6104x&#x2009;&#x002B;&#x2009;0.6259</td>
</tr>
<tr>
<td valign="top" align="left">K</td>
<td valign="top" align="center">0.052</td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">8.238</td>
<td valign="top" align="center">4.226</td>
</tr>
<tr>
<td valign="top" align="left">R<sup>2</sup></td>
<td valign="top" align="center">0.982</td>
<td valign="top" align="center">0.775</td>
<td valign="top" align="center">0.9995</td>
<td valign="top" align="center">0.999</td>
</tr>
<tr>
<td valign="top" align="left">RSS</td>
<td valign="top" align="center">25.101</td>
<td valign="top" align="center">6.372</td>
<td valign="top" align="center">1,486.068</td>
<td valign="top" align="center">0.070</td>
</tr>
<tr>
<td valign="top" align="left">AIC</td>
<td valign="top" align="center">12.587</td>
<td valign="top" align="center">4.361</td>
<td valign="top" align="center">37.073</td>
<td valign="top" align="center">&#x2212;22.747</td>
</tr>
<tr>
<td valign="top" align="left">MSC</td>
<td valign="top" align="center">&#x2212;0.128</td>
<td valign="top" align="center">&#x2212;4.238</td>
<td valign="top" align="center">0.039</td>
<td valign="top" align="center">0.132</td>
</tr>
<tr>
<td valign="top" align="left"><italic>n</italic></td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">0.610</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF1"><p>K, rate constant; R<sup>2</sup>, coefficient of determination; RSS, residual sum square; AIC, Akaike information criterion; MSC, model selection criterion; <italic>n</italic>, release exponential coefficient.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The statistical evaluation further supports the analysis of vitamin C release behavior from both lenses (<xref ref-type="bibr" rid="B40">40</xref>). The rate constant (K) of Senofilcon A was found to be slightly higher than that of Hilafilcon B across all kinetic models, indicating a somewhat faster initial release rate from Senofilcon A. However, Hilafilcon B ultimately achieved a higher cumulative vitamin C concentration, which can be attributed to its greater loading capacity and higher water content that facilitate solute retention and diffusion over time. To minimize the risk of overfitting, AIC values were considered in conjunction with R&#x00B2;. Based on the R&#x00B2; and Akaike Information Criterion (AIC) values, both lenses exhibited lower AIC and higher R&#x00B2; values for the Korsmeyer-Peppas model compared to the Higuchi model, signifying a superior fit and greater predictive reliability. This finding further suggests that the release of vitamin C from both Senofilcon A and Hilafilcon B is governed by a combination of Fickian diffusion and polymer matrix swelling or relaxation, consistent with an anomalous transport mechanism rather than purely diffusion-controlled behavior.</p>
<p>To evaluate the effect of vitamin C incorporation on the hydration behavior and oxygen permeability of the lenses, water content analysis was conducted, as illustrated in <xref ref-type="fig" rid="F9">Figure&#x00A0;9</xref> and summarized in <xref ref-type="table" rid="T5">Table&#x00A0;5</xref>. Hilafilcon B exhibited a statistically significant and substantially higher water content than Senofilcon A across all media (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, unpaired t-test). The equilibrium water content of Hilafilcon B reached approximately 55&#x0025;&#x2013;57&#x0025; and stabilized within the first 30&#x2005;min across all media, whereas Senofilcon A exhibited a lower equilibrium range of 27&#x0025;&#x2013;32&#x0025; with slightly slower hydration, particularly in PBS and vitamin C solutions. The incorporation of vitamin C resulted in a small decrease in water content compared to DI water and PBS for both lens types. However, statistical analysis indicated that this difference was significant only for Hilafilcon B, while the change observed for Senofilcon A was not statistically significant. Overall, the magnitude of the water content reduction was modest, suggesting that vitamin C incorporation does not substantially alter the hydration behavior of the lenses.</p>
<fig id="F9" position="float"><label>Figure&#x00A0;9</label>
<caption><p>Water content of Senofilcon A and Hilafilcon B after soaking in DI water, PBS solution, and vitamin C solution.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fmedt-08-1759039-g009.tif"><alt-text content-type="machine-generated">Line graph showing water content percentage on the y-axis and time in minutes on the x-axis, comparing six conditions: Seno-DI, Seno-PBS, Seno-VC, Hila-DI, Hila-PBS, and Hila-VC. Hila groups reach higher water content near sixty percent, stabilizing quickly, while Seno groups plateau at lower values around thirty percent or less. Error bars are present for each point. A legend indicates line colors for each group.</alt-text>
</graphic>
</fig>
<table-wrap id="T5" position="float"><label>Table&#x00A0;5</label>
<caption><p>Summary of water content and oxygen permeability value of Senofilcon A and Hilafilcon B in different solutions.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Sample</th>
<th valign="top" align="center">Water content (&#x0025;)</th>
<th valign="top" align="center">Oxygen permeability, Dk (barrer)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Seno-DI</td>
<td valign="top" align="center">31.939&#x2009;&#x00B1;&#x2009;1.636</td>
<td valign="top" align="center">5.935</td>
</tr>
<tr>
<td valign="top" align="left">Seno-PBS</td>
<td valign="top" align="center">28.931&#x2009;&#x00B1;&#x2009;1.964</td>
<td valign="top" align="center">5.267</td>
</tr>
<tr>
<td valign="top" align="left">Seno-VC</td>
<td valign="top" align="center">27.039&#x2009;&#x00B1;&#x2009;4.133</td>
<td valign="top" align="center">4.886</td>
</tr>
<tr>
<td valign="top" align="left">Hila-DI</td>
<td valign="top" align="center">57.373&#x2009;&#x00B1;&#x2009;0.325</td>
<td valign="top" align="center">16.289</td>
</tr>
<tr>
<td valign="top" align="left">Hila-PBS</td>
<td valign="top" align="center">56.581&#x2009;&#x00B1;&#x2009;0.307</td>
<td valign="top" align="center">15.785</td>
</tr>
<tr>
<td valign="top" align="left">Hila-VC</td>
<td valign="top" align="center">54.604&#x2009;&#x00B1;&#x2009;0.626</td>
<td valign="top" align="center">14.594</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The observed changes in water content were accompanied by a corresponding decrease in estimated oxygen permeability (Dk). Hilafilcon B displayed higher Dk values (14.6&#x2013;16.3 barrer) than Senofilcon A (4.9&#x2013;5.9 barrer), consistent with oxygen diffusion occurring primarily through hydrated channels in the hydrogel and through the silicone phase in the silicone hydrogel. It should be noted that the oxygen-permeability values reported here are estimated using an empirical water-content-based equation and, therefore, may not fully represent the true oxygen-transport properties of the lenses (<xref ref-type="bibr" rid="B9">9</xref>). Nonetheless, the greater reductions in both water content and estimated Dk in Hilafilcon B suggest a greater extent of vitamin C uptake than in Senofilcon A, owing to its greater hydrophilicity and open polymeric structure. Overall, these results demonstrate that while Hilafilcon B provides superior hydration and oxygen permeability, which are beneficial for ocular comfort, the incorporation of vitamin C may slightly decrease these properties, as reflected in the observed water content trends.</p>
<p>To summarize, <xref ref-type="table" rid="T6">Table&#x00A0;6</xref> presents a comparative overview of the key properties of Senofilcon A and Hilafilcon B, including vitamin C release behavior, equilibrium water content, and oxygen permeability.</p>
<table-wrap id="T6" position="float"><label>Table&#x00A0;6</label>
<caption><p>Summary of Senofilcon A and Hilafilcon B comparison.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Characteristic</th>
<th valign="top" align="center">Senofilcon A</th>
<th valign="top" align="center">Hilafilcon B</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Vitamin C loading capacity</td>
<td valign="top" align="left">9.3&#x2005;&#x00B5;g/mL</td>
<td valign="top" align="left">12&#x2005;&#x00B5;g/mL</td>
</tr>
<tr>
<td valign="top" align="left">Best fit release profile</td>
<td valign="top" align="left">Korsmeyer-Peppas and Higuchi</td>
<td valign="top" align="left">Korsmeyer-Peppas and Higuchi</td>
</tr>
<tr>
<td valign="top" align="left">Vitamin C release mechanism</td>
<td valign="top" align="left">Diffusion and polymer matrix swelling-relaxation (anomalous transport)</td>
<td valign="top" align="left">Diffusion and polymer matrix swelling-relaxation (anomalous transport)</td>
</tr>
<tr>
<td valign="top" align="left">Water content</td>
<td valign="top" align="left">&#x223C; 27&#x0025;&#x2013;32&#x0025;</td>
<td valign="top" align="left">&#x223C; 55&#x0025;&#x2013;57&#x0025;</td>
</tr>
<tr>
<td valign="top" align="left">Oxygen permeability, Dk</td>
<td valign="top" align="left">4.8&#x2013;5.9 barrer</td>
<td valign="top" align="left">14.6&#x2013;16.3 barrer</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s4" sec-type="conclusions"><label>4</label><title>Conclusion</title>
<p>This study developed vitamin C-loaded contact lenses using a simple soaking technique and evaluated their incorporation efficiency, release profile, and stability. Two types of commercial lenses, Senofilcon A and Hilafilcon B, were investigated. The results revealed that Hilafilcon B exhibited higher vitamin C loading and release capacity than Senofilcon A, which is attributed to its greater hydrophilicity and water content. The release kinetics of both lenses followed the Korsmeyer-Peppas model, indicating a non-Fickian or anomalous transport mechanism governed by diffusion and polymer relaxation. Vitamin C stability was influenced by storage temperature and UV exposure, with refrigeration providing optimal preservation. The incorporation of vitamin C slightly reduced the water uptake and oxygen permeability of both lenses, suggesting molecular interaction within the hydrogel matrix.</p>
<p>Future investigations should aim to establish the clinical relevance and safety of this system. Sterility testing and <italic>in vitro</italic> cytotoxicity studies on corneal epithelial or fibroblast cells, followed by <italic>in vivo</italic> evaluation, are recommended to verify ocular compatibility and therapeutic potential. Optimization of loading parameters such as vitamin C concentration, pH, soaking duration, and storage conditions may improve drug retention and release longevity. Long-term stability analysis and exploration of alternative hydrogel materials could further enhance performance. These extensions will support the translation of vitamin C-loaded contact lenses into sterile, sustained-release therapeutic platforms for the management of oxidative stress-related ocular disorders.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="author-contributions"><title>Author contributions</title>
<p>NL: Investigation, Writing &#x2013; original draft, Visualization, Formal analysis, Conceptualization, Methodology, Writing &#x2013; review &#x0026; editing. HB: Writing &#x2013; review &#x0026; editing, Supervision, Conceptualization.</p>
</sec>
<sec id="s8" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s10" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaneev</surname> <given-names>A</given-names></name> <name><surname>Kost</surname> <given-names>O</given-names></name> <name><surname>Chesnokova</surname> <given-names>N</given-names></name> <name><surname>Klyachko</surname> <given-names>N</given-names></name> <name><surname>Beznos</surname> <given-names>O</given-names></name> <name><surname>Popova</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>Nanotechnology for topical drug delivery to the anterior segment of the eye</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>(<issue>22</issue>):<fpage>12368</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222212368</pub-id><pub-id pub-id-type="pmid">34830247</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>YC</given-names></name> <name><surname>Lin</surname> <given-names>MTY</given-names></name> <name><surname>Ng</surname> <given-names>AHC</given-names></name> <name><surname>Wong</surname> <given-names>TT</given-names></name> <name><surname>Mehta</surname> <given-names>JS</given-names></name></person-group>. <article-title>Nanotechnology for the treatment of allergic conjunctival diseases</article-title>. <source>Pharmaceuticals (Basel)</source>. (<year>2020</year>) <volume>13</volume>(<issue>11</issue>):<fpage>351</fpage>. <pub-id pub-id-type="doi">10.3390/ph13110351</pub-id><pub-id pub-id-type="pmid">33138064</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>D</given-names></name> <name><surname>Yan</surname> <given-names>C</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Liu</surname> <given-names>M</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Drug-eluting contact lenses: progress, challenges, and prospects</article-title>. <source>Biointerphases</source>. (<year>2024</year>) <volume>19</volume>(<issue>4</issue>):<fpage>040801</fpage>. <pub-id pub-id-type="doi">10.1116/6.0003612</pub-id><pub-id pub-id-type="pmid">38984804</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubald</surname> <given-names>M</given-names></name> <name><surname>Andrieu</surname> <given-names>V</given-names></name> <name><surname>Bourgeois</surname> <given-names>S</given-names></name> <name><surname>Fessi</surname> <given-names>H</given-names></name></person-group>. <article-title>Ophthalmic drug delivery systems for antibiotherapy-A review</article-title>. <source>Pharmaceutics</source>. (<year>2018</year>) <volume>10</volume>(<issue>1</issue>):<fpage>10</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics10010010</pub-id><pub-id pub-id-type="pmid">29342879</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gote</surname> <given-names>V</given-names></name> <name><surname>Sikder</surname> <given-names>S</given-names></name> <name><surname>Sicotte</surname> <given-names>J</given-names></name> <name><surname>Pal</surname> <given-names>D</given-names></name></person-group>. <article-title>Ocular drug delivery: present innovations and future challenges</article-title>. <source>J Pharmacol Exp Ther</source>. (<year>2019</year>) <volume>370</volume>(<issue>3</issue>):<fpage>602</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.119.256933</pub-id><pub-id pub-id-type="pmid">31072813</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>SW</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name></person-group>. <article-title>Therapeutic contact lenses with polymeric vehicles for ocular drug delivery: a review</article-title>. <source>Materials (Basel)</source>. (<year>2018</year>) <volume>11</volume>(<issue>7</issue>):<fpage>1125</fpage>. <pub-id pub-id-type="doi">10.3390/ma11071125</pub-id><pub-id pub-id-type="pmid">29966397</pub-id></mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioni&#x021B;&#x0103;</surname> <given-names>M</given-names></name> <name><surname>Vl&#x0103;sceanu</surname> <given-names>GM</given-names></name> <name><surname>Toader</surname> <given-names>AG</given-names></name> <name><surname>Manole</surname> <given-names>M</given-names></name></person-group>. <article-title>Advances in therapeutic contact lenses for the management of different ocular conditions</article-title>. <source>J Pers Med</source>. (<year>2023</year>) <volume>13</volume>(<issue>11</issue>):<fpage>1571</fpage>. <pub-id pub-id-type="doi">10.3390/jpm13111571</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname> <given-names>MH</given-names></name> <name><surname>Zahari</surname> <given-names>MAKM</given-names></name> <name><surname>Khan</surname> <given-names>MMR</given-names></name> <name><surname>Beg</surname> <given-names>MDH</given-names></name> <name><surname>Abdullah</surname> <given-names>N</given-names></name></person-group>. <article-title>An overview on recent biomedical applications of biopolymers: their role in drug delivery systems and comparison of major systems</article-title>. <source>J Drug Deliv Sci Technol</source>. (<year>2023</year>) <volume>80</volume>:<fpage>104121</fpage>. <pub-id pub-id-type="doi">10.1016/j.jddst.2022.104121</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname> <given-names>K</given-names></name> <name><surname>Jones</surname> <given-names>LW</given-names></name> <name><surname>Morgan</surname> <given-names>P</given-names></name> <name><surname>Papas</surname> <given-names>EB</given-names></name> <name><surname>Sulley</surname> <given-names>A</given-names></name></person-group>. <article-title>Topical review: twenty-five years of silicone hydrogel soft contact lenses</article-title>. <source>Optom Vis Sci</source>. (<year>2025</year>) <volume>102</volume>(<issue>6</issue>):<fpage>361</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1097/OPX.0000000000002267</pub-id><pub-id pub-id-type="pmid">40549698</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tram</surname> <given-names>NK</given-names></name> <name><surname>McLean</surname> <given-names>RM</given-names></name> <name><surname>Swindle-Reilly</surname> <given-names>KE</given-names></name></person-group>. <article-title>Glutathione improves the antioxidant activity of vitamin C in human Lens and retinal epithelial cells: implications for vitreous substitutes</article-title>. <source>Curr Eye Res</source>. (<year>2021</year>) <volume>46</volume>(<issue>4</issue>):<fpage>470</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1080/02713683.2020.1809002</pub-id><pub-id pub-id-type="pmid">32838548</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hah</surname> <given-names>YS</given-names></name> <name><surname>Chung</surname> <given-names>HJ</given-names></name> <name><surname>Sontakke</surname> <given-names>SB</given-names></name> <name><surname>Chung</surname> <given-names>IY</given-names></name> <name><surname>Ju</surname> <given-names>S</given-names></name> <name><surname>Seo</surname> <given-names>SW</given-names></name><etal/></person-group> <article-title>Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study</article-title>. <source>BMC Ophthalmol</source>. (<year>2017</year>) <volume>17</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1186/s12886-017-0515-2</pub-id><pub-id pub-id-type="pmid">28068950</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname> <given-names>YJ</given-names></name> <name><surname>Tsao</surname> <given-names>YT</given-names></name> <name><surname>Chen</surname> <given-names>YN</given-names></name> <name><surname>Cheng</surname> <given-names>CM</given-names></name> <name><surname>Chen</surname> <given-names>HC</given-names></name> <name><surname>Wu</surname> <given-names>WC</given-names></name></person-group>. <article-title>The pathomechanism, antioxidant biomarkers, and treatment of oxidative stress-related eye diseases</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>(<issue>3</issue>):<fpage>1255</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23031255</pub-id><pub-id pub-id-type="pmid">35163178</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname> <given-names>DY</given-names></name> <name><surname>Chaudhary</surname> <given-names>S</given-names></name> <name><surname>Cho</surname> <given-names>KS</given-names></name> <name><surname>Lennikov</surname> <given-names>A</given-names></name> <name><surname>Miller</surname> <given-names>WP</given-names></name> <name><surname>Thorn</surname> <given-names>DC</given-names></name><etal/></person-group> <article-title>Role of oxidative stress in ocular diseases: a balancing act</article-title>. <source>Metabolites</source>. (<year>2023</year>) <volume>13</volume>(<issue>2</issue>):<fpage>187</fpage>.<pub-id pub-id-type="pmid">36837806</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushwah</surname> <given-names>N</given-names></name> <name><surname>Maurya</surname> <given-names>M</given-names></name> <name><surname>Bora</surname> <given-names>K</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Pavlovich</surname> <given-names>MC</given-names></name></person-group>. <article-title>Oxidative stress and antioxidants in age-related macular degeneration</article-title>. <source>Antioxidants</source>. (<year>2023</year>) <volume>12</volume>(<issue>7</issue>):<fpage>1379</fpage>. <pub-id pub-id-type="doi">10.3390/antiox12071379</pub-id><pub-id pub-id-type="pmid">37507918</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>A</given-names></name> <name><surname>Baker</surname> <given-names>D</given-names></name> <name><surname>Jenyon</surname> <given-names>T</given-names></name></person-group>. <source>The Role of Vitamin C in the Prevention of Corneal Endothelial Loss Post Phacoemulsification</source>. Vol. <volume>45</volume>. <publisher-name>International Ophthalmology. Springer Science and Business Media B.V.</publisher-name> (<year>2025</year>).</mixed-citation></ref>
<ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gujral</surname> <given-names>GS</given-names></name> <name><surname>Askari</surname> <given-names>SN</given-names></name> <name><surname>Ahmad</surname> <given-names>S</given-names></name> <name><surname>Zakir</surname> <given-names>SM</given-names></name> <name><surname>Saluja</surname> <given-names>K</given-names></name></person-group>. <article-title>Topical vitamin C, vitamin E, and acetylcysteine as corneal wound healing agents: a comparative study</article-title>. <source>Indian J Ophthalmol</source>. (<year>2020</year>) <volume>68</volume>(<issue>12</issue>):<fpage>2935</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4103/ijo.IJO_1463_20</pub-id><pub-id pub-id-type="pmid">33229673</pub-id></mixed-citation></ref>
<ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name> <name><surname>Backman</surname> <given-names>LJ</given-names></name> <name><surname>Danielson</surname> <given-names>P</given-names></name> <name><surname>Zhou</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Ascorbic acid promotes the stemness of corneal epithelial stem/progenitor cells and accelerates epithelial wound healing in the Cornea</article-title>. <source>Stem Cells Transl Med</source>. (<year>2017</year>) <volume>6</volume>(<issue>5</issue>):<fpage>1356</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/srep25870</pub-id><pub-id pub-id-type="pmid">28276172</pub-id></mixed-citation></ref>
<ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudana</surname> <given-names>R</given-names></name> <name><surname>Ananthula</surname> <given-names>HK</given-names></name> <name><surname>Parenky</surname> <given-names>A</given-names></name> <name><surname>Mitra</surname> <given-names>AK</given-names></name></person-group>. <article-title>Ocular drug delivery</article-title>. <source>AAPS J</source>. (<year>2010</year>) <volume>12</volume>(<issue>3</issue>):<fpage>348</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-010-9183-3</pub-id><pub-id pub-id-type="pmid">20437123</pub-id></mixed-citation></ref>
<ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J</given-names></name> <name><surname>Pelis</surname> <given-names>RM</given-names></name></person-group>. <article-title>Drug transport by the blood-aqueous humor barrier of the eye</article-title>. <source>Drug Metab Dispos</source>. (<year>2016</year>) <volume>44</volume>(<issue>10</issue>):<fpage>1675</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.116.069369</pub-id><pub-id pub-id-type="pmid">26895982</pub-id></mixed-citation></ref>
<ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiatt</surname> <given-names>AN</given-names></name> <name><surname>Taylor</surname> <given-names>LS</given-names></name> <name><surname>Mauer</surname> <given-names>LJ</given-names></name></person-group>. <article-title>Influence of simultaneous variations in temperature and relative humidity on chemical stability of two vitamin C forms and implications for shelf life models</article-title>. <source>J Agric Food Chem</source>. (<year>2010</year>) <volume>58</volume>(<issue>6</issue>):<fpage>3532</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1021/jf903342f</pub-id><pub-id pub-id-type="pmid">20163110</pub-id></mixed-citation></ref>
<ref id="B21"><label>21.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bruschi</surname> <given-names>ML</given-names></name></person-group>. <source>Mathematical Models of Drug Release. Vol. 5, Strategies to Modify the Drug Release from Pharmaceutical Systems</source>. <publisher-loc>Cambridge</publisher-loc>: <publisher-name>Woodhead Publishing</publisher-name> (<year>2015</year>). p. <fpage>63</fpage>&#x2013;<lpage>86</lpage>.</mixed-citation></ref>
<ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname> <given-names>MH</given-names></name> <name><surname>Al Qubro</surname> <given-names>K</given-names></name> <name><surname>Khan</surname> <given-names>MMR</given-names></name> <name><surname>Zahari</surname> <given-names>MAKM</given-names></name> <name><surname>Abdullah</surname> <given-names>N</given-names></name></person-group>. <article-title>An insight into the drug release kinetics of polylactic acid/chitosan/nanocellulose nanofibers: effect of preparation method on drug release kinetics</article-title>. <source>J Polym Sci A</source>. (<year>2025</year>) <volume>63</volume>(<issue>22</issue>):<fpage>4829</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1002/pol.20250609</pub-id></mixed-citation></ref>
<ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname> <given-names>S</given-names></name> <name><surname>Yadav</surname> <given-names>KS</given-names></name></person-group>. <article-title>Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment</article-title>. <source>DARU Journal of Pharmaceutical Sciences</source>. (<year>2023</year>) <volume>32</volume>(<issue>1</issue>):<fpage>161</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1007/s40199-023-00500-z</pub-id><pub-id pub-id-type="pmid">38158475</pub-id></mixed-citation></ref>
<ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rykowska</surname> <given-names>I</given-names></name> <name><surname>Micha&#x0142;kiewicz</surname> <given-names>O</given-names></name> <name><surname>Nowak</surname> <given-names>I</given-names></name> <name><surname>Nowak</surname> <given-names>R</given-names></name></person-group>. <article-title>Drug-Modified contact lenses&#x2014;properties, release kinetics, and stability of active substances with particular emphasis on cyclosporine A: a review</article-title>. <source>Molecules</source>. (<year>2024</year>) <volume>29</volume>(<issue>11</issue>):<fpage>2609</fpage>. <pub-id pub-id-type="doi">10.3390/molecules29112609</pub-id><pub-id pub-id-type="pmid">38893485</pub-id></mixed-citation></ref>
<ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname> <given-names>P</given-names></name> <name><surname>Shokrollahi</surname> <given-names>P</given-names></name> <name><surname>Darge</surname> <given-names>HF</given-names></name> <name><surname>Phan</surname> <given-names>CM</given-names></name> <name><surname>Jones</surname> <given-names>L</given-names></name></person-group>. <article-title>Controlled PVA release from chemical-physical interpenetrating networks to treat dry eyes</article-title>. <source>ACS Omega</source>. (<year>2024</year>) <volume>10</volume>:<fpage>1249</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.4c08667</pub-id><pub-id pub-id-type="pmid">39829547</pub-id></mixed-citation></ref>
<ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Fan</surname> <given-names>Q</given-names></name> <name><surname>Huo</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>C</given-names></name> <name><surname>Li</surname> <given-names>B</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name></person-group>. <article-title>Construction of a mesoporous polydopamine@GO/cellulose nanofibril composite hydrogel with an encapsulation structure for controllable drug release and toxicity shielding</article-title>. <source>ACS Appl Mater Interfaces</source>. (<year>2020</year>) <volume>12</volume>(<issue>51</issue>):<fpage>57410</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.0c15465</pub-id><pub-id pub-id-type="pmid">33289538</pub-id></mixed-citation></ref>
<ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname> <given-names>P</given-names></name> <name><surname>Shokrollahi</surname> <given-names>P</given-names></name> <name><surname>Darge</surname> <given-names>HF</given-names></name> <name><surname>Phan</surname> <given-names>CM</given-names></name> <name><surname>Jones</surname> <given-names>L</given-names></name></person-group>. <article-title>3D-Printed Contact lenses to release polyvinyl alcohol as a therapeutic agent for the treatment of dry eyes</article-title>. <source>Pharmaceutics</source>. (<year>2025</year>) <volume>17</volume>(<issue>2</issue>):<fpage>219</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics17020219</pub-id><pub-id pub-id-type="pmid">40006586</pub-id></mixed-citation></ref>
<ref id="B28"><label>28.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Elmas</surname> <given-names>A</given-names></name> <name><surname>Aky&#x00FC;z</surname> <given-names>G</given-names></name> <name><surname>Bergal</surname> <given-names>A</given-names></name> <name><surname>Anda&#x00E7;</surname> <given-names>M</given-names></name> <name><surname>Anda&#x00E7;</surname> <given-names>&#x00D6;</given-names></name></person-group>. <source>Mathematical Modelling of Drug Release. Vol. 6, Research on Engineering Structures and Materials</source>. <publisher-name>MIM RESEARCH GROUP</publisher-name> (<year>2020</year>). p. <fpage>327</fpage>&#x2013;<lpage>50</lpage>.</mixed-citation></ref>
<ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>C</given-names></name> <name><surname>Garc&#x00ED;a-Montero</surname> <given-names>M</given-names></name> <name><surname>Courtis</surname> <given-names>A</given-names></name> <name><surname>Hainey</surname> <given-names>P</given-names></name> <name><surname>Madrid-Costa</surname> <given-names>D</given-names></name> <name><surname>Crooke</surname> <given-names>A</given-names></name></person-group>. <article-title>Optimization of the oxygen permeability of non-silicone hydrogel contact lenses through crosslinking modifications</article-title>. <source>Gels</source>. (<year>2024</year>) <volume>10</volume>(<issue>11</issue>):<fpage>726</fpage>. <pub-id pub-id-type="doi">10.3390/gels10110726</pub-id><pub-id pub-id-type="pmid">39590082</pub-id></mixed-citation></ref>
<ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname> <given-names>BA</given-names></name> <name><surname>Buettner</surname> <given-names>GR</given-names></name></person-group>. <article-title>Stability of aqueous solutions of ascorbate for basic research and for intravenous administration</article-title>. <source>Advances in Redox Research</source>. (<year>2023</year>) <volume>9</volume>:<fpage>100077</fpage>. <pub-id pub-id-type="doi">10.1016/j.arres.2023.100077</pub-id><pub-id pub-id-type="pmid">37808406</pub-id></mixed-citation></ref>
<ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demtschuk</surname> <given-names>M</given-names></name> <name><surname>Heinz</surname> <given-names>P</given-names></name></person-group>. <article-title>Systematic review of different methods for the quantification of vitamin C in human plasma samples by HPLC and UV detector</article-title>. <source>Analytica</source>. (<year>2026</year>) <volume>7</volume>(<issue>1</issue>):<fpage>2</fpage>. <pub-id pub-id-type="doi">10.3390/analytica7010002</pub-id></mixed-citation></ref>
<ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caban</surname> <given-names>M</given-names></name> <name><surname>Lenard</surname> <given-names>K</given-names></name> <name><surname>Nowak</surname> <given-names>A</given-names></name> <name><surname>Dzimitrowicz</surname> <given-names>A</given-names></name></person-group>. <article-title>New method for quantification of ascorbic acid in fruit juices with an application of ionic liquids as phase modifier in reverse phase HPLC</article-title>. <source>Microchem J</source>. (<year>2025</year>) <volume>215</volume>:<fpage>114440</fpage>. <pub-id pub-id-type="doi">10.1016/j.microc.2025.114440</pub-id></mixed-citation></ref>
<ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeney-Nagymate</surname> <given-names>E</given-names></name> <name><surname>Fodor</surname> <given-names>P</given-names></name></person-group>. <article-title>The stability of vitamin C in different beverages</article-title>. <source>British Food Journal</source>. (<year>2008</year>) <volume>110</volume>(<issue>3</issue>):<fpage>296</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1108/00070700810858709</pub-id></mixed-citation></ref>
<ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temova Raku&#x0161;a</surname> <given-names>&#x017D;</given-names></name> <name><surname>Ro&#x0161;kar</surname> <given-names>R</given-names></name> <name><surname>Pi&#x0161;lar</surname> <given-names>M</given-names></name> <name><surname>Kristl</surname> <given-names>A</given-names></name></person-group>. <article-title>Comprehensive stability study of vitamin D3 in aqueous solutions and liquid commercial products</article-title>. <source>Pharmaceutics</source>. (<year>2021</year>) <volume>13</volume>(<issue>5</issue>):<fpage>617</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics13050617</pub-id></mixed-citation></ref>
<ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname> <given-names>K</given-names></name> <name><surname>Garv&#x00ED;n</surname> <given-names>A</given-names></name> <name><surname>Lara-Sagah&#x00F3;n</surname> <given-names>AV</given-names></name> <name><surname>Ibarz</surname> <given-names>A</given-names></name></person-group>. <article-title>Ascorbic acid degradation in aqueous solution during UV-vis irradiation</article-title>. <source>Food Chem</source>. (<year>2019</year>) <volume>297</volume>:<fpage>124864</fpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2019.05.138</pub-id><pub-id pub-id-type="pmid">31253321</pub-id></mixed-citation></ref>
<ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tikekar</surname> <given-names>RV</given-names></name> <name><surname>Anantheswaran</surname> <given-names>RC</given-names></name> <name><surname>LaBorde</surname> <given-names>LF</given-names></name></person-group>. <article-title>Ascorbic acid degradation in a model apple juice system and in apple juice during ultraviolet processing and storage</article-title>. <source>J Food Sci</source>. (<year>2011</year>) <volume>76</volume>(<issue>2</issue>):<fpage>H62</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3841.2010.02015.x</pub-id><pub-id pub-id-type="pmid">21535769</pub-id></mixed-citation></ref>
<ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname> <given-names>I</given-names></name> <name><surname>Sheraz</surname> <given-names>MA</given-names></name> <name><surname>Ahmed</surname> <given-names>S</given-names></name> <name><surname>Shaikh</surname> <given-names>RH</given-names></name> <name><surname>Vaid</surname> <given-names>FHM</given-names></name> <name><surname>Ur Rehman Khattak</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Photostability and interaction of ascorbic acid in cream formulations</article-title>. <source>AAPS PharmSciTech</source>. (<year>2011</year>) <volume>12</volume>(<issue>3</issue>):<fpage>917</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1208/s12249-011-9659-1</pub-id><pub-id pub-id-type="pmid">21735345</pub-id></mixed-citation></ref>
<ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>K</given-names></name> <name><surname>Cheng</surname> <given-names>H</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Feng</surname> <given-names>S</given-names></name> <name><surname>Song</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Chemical stability of ascorbic acid integrated into commercial products: a review on bioactivity and delivery technology</article-title>. <source>Antioxidants</source>. (<year>2022</year>) <volume>11</volume>(<issue>1</issue>):<fpage>153</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11010153</pub-id><pub-id pub-id-type="pmid">35052657</pub-id></mixed-citation></ref>
<ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname> <given-names>S</given-names></name> <name><surname>Shaik</surname> <given-names>L</given-names></name> <name><surname>Chakraborty</surname> <given-names>S</given-names></name></person-group>. <article-title>Effect of ultraviolet and pulsed light treatments on ascorbic acid content in fruit juices-A review of the degradation mechanism</article-title>. <source>Food Chemistry Advances</source>. (<year>2023</year>) <volume>2</volume>:<fpage>100333</fpage>. <pub-id pub-id-type="doi">10.1016/j.focha.2023.100333</pub-id></mixed-citation></ref>
<ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koduri</surname> <given-names>SC</given-names></name> <name><surname>Napoleon</surname> <given-names>AA</given-names></name></person-group>. <article-title>Mathematical model application for <italic>in vitro</italic> release kinetics of ranolazine extended-release tablets</article-title>. <source>Dissolut Technol</source>. (<year>2024</year>) <volume>31</volume>(<issue>4</issue>):<fpage>182</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.14227/DT310424P182</pub-id></mixed-citation></ref>
<ref id="B41"><label>41.</label><mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Ani Jose</surname> <given-names>P</given-names></name> <name><surname>Mallikarjuna Setty</surname> <given-names>C</given-names></name></person-group>. <comment>Release kinetics-concepts and applications</comment> (<year>2018</year>). <comment>Available online at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/publication/369038187">https://www.researchgate.net/publication/369038187</ext-link> <comment>(Accessed October 30, 2025).</comment></mixed-citation></ref>
<ref id="B42"><label>42.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Askarizadeh</surname> <given-names>M</given-names></name> <name><surname>Esfandiari</surname> <given-names>N</given-names></name> <name><surname>Honarvar</surname> <given-names>B</given-names></name> <name><surname>Sajadian</surname> <given-names>SA</given-names></name> <name><surname>Azdarpour</surname> <given-names>A</given-names></name></person-group>. <source>Kinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems. Vol. 10, ChemBioEng Reviews</source>. <publisher-name>John Wiley and Sons Inc</publisher-name> (<year>2023</year>). p. <fpage>1006</fpage>&#x2013;<lpage>49</lpage>.</mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1801293/overview">Fei Deng</ext-link>, University of New South Wales, Australia</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3179753/overview">Paresh Patel</ext-link>, Uka Tarsadia University, India</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3329589/overview">Murtaza Haider Syed</ext-link>, Universiti Malaysia Pahang, Malaysia</p></fn>
</fn-group>
</back>
</article>